India's SeQuent Scientific climbs most in near 3 months after nod for plant sale
** Shares of SeQuent Scientific SEQU.NS climb as much as 9.5% to 96.15
rupees; logging their best pct gain since June 22
** The animal healthcare co says it approved a sale of its drug ingredient
facility in Thane, Maharashtra; deal value not disclosed
** Stock hits highest since Aug. 31
** Nearly 7.5 mln shares change hands, 4.2x the 30-day average of ~1.8 mln
shares
** Stock remains flat this year, as of last close
(Reporting by Archishma Iyer in Bengaluru)
((Archishma.Iyer@thomsonreuters.com;))
Recent news on Viyash Scientific
See all newsBrief: Viyash Scientific Says Bioforlife Italia Acquisition Expected To Complete Within Two Months From Sept 8
Brief: Viyash Scientific Ltd June-Quarter Consol Net Profit 658.7 Million Rupees
Brief: Viyash Scientific's Subsidiary To Buy 100% Of Bioforlife Italia
Brief: Viyash Scientific March-Quarter Consol Net Profit 521.1 Million Rupees
Brief: Viyash Scientific Partners With Boehringer Ingelheim In India